Epstein-Barr virus-associated lymphomas (Q56930876)

23 March 2019

3 April 2019

20 June 2019

30 June 2019

21 October 2019

3 November 2019

18 September 2020

on focus list of Wikimedia project

1 December 2020

ScienceSource

0 references

cites work

Epstein-Barr virus: more than 50 years old and still providing surprises.

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The pathogenesis of Epstein-Barr virus persistent infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Post-transplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Germinal centres and B cell lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The tumor virus landscape of AIDS-related lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Molecular diagnosis of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Structure and consequences of IGH switch breakpoints in Burkitt lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Role of genetic and epigenetic changes in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The genetic landscape of mutations in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Oncogenic mechanisms in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The curious case of the tumour virus: 50 years of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Genetics of Epstein-Barr virus microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus maintains lymphomas via its miRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr viral microRNAs target caspase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Co-infections, inflammation and oncogenesis: future directions for EBV research

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epidemiology: clues to the pathogenesis of Burkitt lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Hodgkin's lymphoma: the pathologist's viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Hodgkin lymphoma: Pathology and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Pathology of lymphoma in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The molecular pathogenesis of Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

NF-κB deregulation in Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

EBV-positive diffuse large B-cell lymphoma of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Pathogenesis of human B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Diffuse large B-cell lymphoma associated with chronic inflammation in metallic implant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Metallic implant-associated lymphoma: a distinct subgroup of large B-cell lymphoma related to pyothorax-associated lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

HLA-A alleles of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Sequences of cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus (EBV) nuclear antigen-3B gene in a Japanese population with or without EBV-positive lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

The Seville expert workshop for progress in posttransplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Mutational landscape of B-cell post-transplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

A lymphomagenic role for HIV beyond immune suppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Prognostic factors for chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Primary Immunodeficiencies Associated with EBV Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Human immunity against EBV-lessons from the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Molecular underpinning of extranodal NK/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Comprehensive molecular characterization of gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus-induced epigenetic alterations following transient infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Epstein-Barr virus and Burkitt lymphoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Current management of nasal NK/T-cell lymphoma.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Defective killer cell activity in patients with chronic active Epstein-Barr virus infection

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5597738

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

2 November 2018

1 reference

https://api.crossref.org/works/10.1098%2FRSTB.2016.0271

Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells

21 January 2018

1 reference

12 December 2020

Role of an immunosuppressive cytokine, interleukin-10, in the development of pyothorax-associated lymphoma

1 reference

12 December 2020

The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV-negative cases of classical Hodgkin's lymphoma

1 reference

12 December 2020

Interleukin-6-mediated growth enhancement of cell lines derived from pyothorax-associated lymphoma

1 reference

12 December 2020

Post-transplant lymphoproliferative disorders

1 reference

12 December 2020

Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years

1 reference

12 December 2020